To determine the cardiovascular and respiratory effects of intravenous ketamine in the neonatal
Ketamine hydrochloride is an agent frequently recommended for the induction of anaesthesia in children with congenital heart defects 1-4 and for sedation during cardiac catheterization. 5'6 It is also recommended for sedation of unco-operative neonates, infants and children for diagnostic procedures such as computerized tomography. 7's Although ketamine provides a stable level of anaesthesia, excellent analgesia, maintenance of respiratory reflexes and drive and maintenance of cardiovascular function, 9.1~ it has been reported to produce hypoxaemia and elevations in pulmonary vascular resistance (Rp). 11-t3 The cardiovascular effects of intravenous ketamine have been studied in both animals and humans, 11-14 but its effects in infants are not clear. Ketamine is reported to have no significant influence on the circulation in children either before or after surgical repair of their congenital heart lesions. ~s-~7 Hickey et al. 17 suggested that the effects of ketamine in children apply to infants with similar defects. However, the myocardium and pulmonary circulation differ markedly between infants and children.
Futhermore, there is no study on the effect of the administration of ketamine on the cardiovascular system of the intact normal neonate or infant. Extrapolation of work done in children with congenital heart defects may not be relevant as their results may reflect the influence of the disease process on the myocardium and the pulmonary circulation. The purpose of our study, therefore, was to examine the effect of ketamine on the cardiovascular variables in the neonatal lamb model with a normal cardiovascular system.
Methods
We studied six chronically instrumented newborn lambs weighing <6 kg and less than eight days old. Each animal had undergone a lateral thoracotomy The electroencephalogram (EEG) was monitored by standard bipolar parietal leads. Heart rate (HR) was calculated from the peak-to-peak interval of the arterial pressure trace. The data were recorded simultaneously on an Electronics for Medicine | 12-channel recorder. Arterial blood gas analysis (pH, PCO2, PO2 and base excess) was performed (Coming 165 | ) Volume equivalent to blood withdrawn for analysis (approximately 10 nal) was transfused into the lamb immediately after sampling.
The study was performed on Day 5. Recovery from surgery was assessed solely by observation of the animal. The animal was considered suitable for further study if there were no signs of infection or obvious restriction of movement due to the site of surgery.
The lambs were suspended in a sling in the upright position and were nursed from a bottle. The transducers were mounted on a rack next to the animal at mid-thoracic level. To provide a quiet environment for the lambs all equipment was positioned outside the room and the animal was visualized with a remote camera.
Each lamb was studied twice: first, 1 mg'kg -~ ketamine was administered and then, after return of the EEG and cardiovascular variables to control levels (at least one hour), 2 mg'kg -1 ketamine was administered. The ketamine was administered into the LA line over 30 seconds. During each study, control measurements were made immediately before ketamine administration.
Systemic vascular resistance (Rs) was calculated from the formula: 
Results
The control values for MAP, PAP, LAP, HR, RR, Qp, Rp, Rs and Rp.Rs -1 did not differ significantly between the two doses of ketamine (Figures 1-3) . Only RR changed significantly during the study periods. Control RR was 48.17 +-4.98 breaths per minute (BPM) before ketamine I mg.kg -1 and 52.2 ~ 3.47 BPM before ketamine 2 mg'kg -~. RR increased significantly reaching a maximum two minutes after administration of either dose of ketamine (80 + 7.96 BPM for ketamine 1 mg.kgand 95.4 -+ 8.17 BPM after ketamine 2 mg.kg-~). RR no longer differed significantly from control six minutes after the administration of ketamine 1 mg'kg -I but still significantly increased (68.2 -11.61 BPM) above control ten minutes after the administration of ketamine 2 mg-kg-1. Arterial pH, There was no statistical difference in any variable between the two doses of ketamine.
Discussion
Ketamine (1 mg.kg -I or 2mg'kg -1) produced no significant cardiovascular changes when administered to neonatal lambs with normal, intact cardiovascular anatomy. However, it did increase the respiratory rate without significant changes in the arterial blood gases.
The effect of ketamine on the cardiovascular system varies with age. In adults, ketamine stimulates the cardiovascular system. 18-22 In the absence of autonomic control, however, ketamine directly depresses the myocardium. 23'24 The effect of ketamine on the cardiovascular system in children is not clear. In children undergoing cardiac catheterization, previous studies reported increases in blood pressure 15 and heart rate 16 while others reported no change in blood pressure, heart rate or cardiac index. 17 Our data suggest the lack of significant effect of ketamine on the cardiovascular system in neonatal lambs.
Ketamine increases the pulmonary artery pressure and pulmonary vascular resistance in adults t2'14'25 and in children. 16 In infants and neonates, however, our results and other recent findings suggest ketamine 1 or 2 mg'kg-~ has no significant effect on either the pulmonary artery pressure or the pulmonary vascular resistance (Rp.Rs-I). t7 This age-related difference in responses to ketamine is not fully understood. Abdalla et al. suggested the responses in infants may reflect an immaturity of innervation of the pulmonary vasculature and the myocardium. 26 The enhanced responses with increasing age may reflect an increasing maturity of innervation in the pulmonary vasculature. J6 We believe this explanation is unlikely since both infants and neonates have demonstrated increased pulmonary vascular reactivity to a variety of stimuli.27 Because ketamine has a dual effect on vascular smooth muscle (a direct effect causing vasodilatation and an indirect effect causing vasoconstriction), demonstrated in older animals, the net effect on the systemic vascular resistance is minimal. ~3,2s This result is demonstrated as well in the studies on children, 16 infants 17 and our own study in neonatal lambs.
Hickey et al. 17 postulated that discrepancies in the effect of ketamine on the pulmonary vasculature were indirect effects of ketamine on the airway and ventilation. They demonstrated minimal haemodynamic response to ketamine in subjects whose airway and ventilation were maintained. This postulate is supported by studies in which haemodynamic changes were demonstrated only in association with significant changes in pH and PO2. J2.z3, 25 The increase in RR after ketamine in this study occurred although there was no evidence of hypoxia, hypercapnia or acidosis. The stability of the arterial blood gases leads us to speculate the increased RR was coincident with a decreased tidal volume, with the minute ventilation remaining unchanged. Adults breathing spontaneously in room air demonstrate significant reductions in arterial oxygenation and minute ventilation after the administration of ketamine 2 mg.kg -1 intravenously as a rapid bolus. 14.29 In contrast, patients premedicated with diazepam 10-15 mg intramuscularly and spontaneously breathing room air who received ketamine 2 mg.kg -1 intravenously over 60 seconds showed no significant change in arterial oxygenation or shunt fraction. 30 Furthermore, the administration of an infusion of ketamine I mg.kg -j intravenously during vaginal deliveries produced no significant changes in maternal or infant arterial blood gases. 31 The respiratory response to carbon dioxide is maintained during ketamine anaesthesia and ketamine does not produce significant respiratory depression except when it is given as a rapid intravenous bolus. Increased RR has not been demonstrated previously and may represent an effect on an immature respiratory center or a reflex response to the injection of the drug into the left atrium, although such a reflex has not been described.
Care should be exercised when using ketamine in the critically ill newborn. Although we demonstrated no statistically significantly increase from control levels of HR or MAP, there is a trend towards an increase and the potential for increased cerebral perfusion pressure and consequently, cerebral blood flow is present. Because of the possible relationship between increased cerebral blood flow and intraventricular haemorrhage, blood pressure and heart rate must be monitored carefully during administration of ketamine. 32-34 Ketamine has no significant effect on the cardiovascular system in healthy neonatal lambs, but it does increase the respiratory rate although pulmonary gas exchange is unaffected. This confirms our clinical impression of the safety and stability of utilizing ketamine as a sedative/anaesthetic agent in healthy neonates.
